Tomi Virtanen will begin as the new CEO of Immuno Diagnostic Oy
Our current CEO Jarmo Laakkonen has decided to pursue other endeavors and as of June 1st 2021 current Sales Director Tomi Virtanen will begin as the new CEO of Immuno Diagnostic Oy.
We want to thank Jarmo for his long career at Immuno, since 1998 and as CEO since 2008 and his achievements when growing a family business into one of the major companies in our specialty. At the same time we welcome Tomi and wish him all the best in his new role.
Tomi has an extensive experience in Management and Sales in the laboratory instrument,
industrial and diagnostics markets and has acted as the Sales Director in Immuno Diagnostic since
September 2020. Jarmo will be acting as a senior advisor in business development in the company.
Since 1983, The company has not only grown strongly, but has become one of Finland’s most
important players in diagnostics and research. The background and culture of the originally family-owned business can be seen in our day-to-day work, bringing speed and flexibility to our operations, while at the same time respecting the core values of AddLife Group. The strong expertise of our personnel, our digital visibility and long-term customer and supplier relationships provide a good base for the coming years.